20/09/2021
another one :)
Our October issue is out! Don't miss it at https://bit.ly/3ltbkof
Read about the molecular characteristics of HCC in NASH, how the surveillance of patients with cirrhosis in the US remains suboptimal, the burden of NAFLD in Asia, Middle East and North Africa, the 12 vs. 6 weeks treatment with sofosbuvir/velpatasvir in recently acquired hepatitis C and much much more!